De Santo NG - Search Results

1

The gasotransmitter hydrogen sulfide in hemodialysis patients.

Perna AF, Sepe I, Lanza D, Capasso R, Di Marino V, De Santo NG, Ingrosso D. Perna AF, et al. Among authors: de santo ng. J Nephrol. 2010 Nov-Dec;23 Suppl 16:S92-6. J Nephrol. 2010. PMID: 21170893 Review.

2

L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis.

Perna AF, Acanfora F, Satta E, Lombardi C, Capasso R, Ingrosso D, De Santo NG. Perna AF, et al. Among authors: de santo ng. J Nephrol. 2007 Jan-Feb;20(1):63-5. J Nephrol. 2007. PMID: 17347975 Clinical Trial.

3

Hydrogen sulphide-generating pathways in haemodialysis patients: a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes.

Perna AF, Luciano MG, Ingrosso D, Pulzella P, Sepe I, Lanza D, Violetti E, Capasso R, Lombardi C, De Santo NG. Perna AF, et al. Among authors: de santo ng. Nephrol Dial Transplant. 2009 Dec;24(12):3756-63. doi: 10.1093/ndt/gfp378. Epub 2009 Aug 4. Nephrol Dial Transplant. 2009. PMID: 19654230

4

Hydrogen sulfide, the third gaseous signaling molecule with cardiovascular properties, is decreased in hemodialysis patients.

Perna AF, Luciano MG, Ingrosso D, Raiola I, Pulzella P, Sepe I, Lanza D, Violetti E, Capasso R, Lombardi C, De Santo NG. Perna AF, et al. Among authors: de santo ng. J Ren Nutr. 2010 Sep;20(5 Suppl):S11-4. doi: 10.1053/j.jrn.2010.05.004. J Ren Nutr. 2010. PMID: 20797558 Review.

5

Hydrogen sulfide, a toxic gas with cardiovascular properties in uremia: how harmful is it?

Perna AF, Lanza D, Sepe I, Raiola I, Capasso R, De Santo NG, Ingrosso D. Perna AF, et al. Among authors: de santo ng. Blood Purif. 2011;31(1-3):102-6. doi: 10.1159/000321838. Epub 2011 Jan 10. Blood Purif. 2011. PMID: 21228576 Free article.

6

Hyperhomocysteinemia in chronic renal failure: alternative therapeutic strategies.

Perna AF, Sepe I, Lanza D, Pollastro RM, De Santo NG, Ingrosso D. Perna AF, et al. Among authors: de santo ng. J Ren Nutr. 2012 Jan;22(1):191-4. doi: 10.1053/j.jrn.2011.10.008. J Ren Nutr. 2012. PMID: 22200441 Review.

7

Toxic effects of hyperhomocysteinemia in chronic renal failure and in uremia: cardiovascular and metabolic consequences.

Perna AF, Capasso R, Acanfora F, Satta E, Lombardi C, Ingrosso D, Violetti E, Romano MM, De Santo NG. Perna AF, et al. Among authors: de santo ng. Semin Nephrol. 2006 Jan;26(1):20-3. doi: 10.1016/j.semnephrol.2005.06.005. Semin Nephrol. 2006. PMID: 16412820 Review.

8

Do elevated homocysteine levels predict mortality in chronic kidney disease stages 3-4?

De Santo NG, Perna AF. De Santo NG, et al. Nat Clin Pract Nephrol. 2006 Nov;2(11):614-5. doi: 10.1038/ncpneph0314. Nat Clin Pract Nephrol. 2006. PMID: 17066049 No abstract available.

9

Plasma protein homocysteinylation in uremia.

Perna AF, Acanfora F, Luciano MG, Pulzella P, Capasso R, Satta E, Cinzia L, Pollastro RM, Iannelli S, Ingrosso D, De Santo NG. Perna AF, et al. Among authors: de santo ng. Clin Chem Lab Med. 2007;45(12):1678-82. doi: 10.1515/CCLM.2007.336. Clin Chem Lab Med. 2007. PMID: 17937608 Review.

10

Is homocysteine toxic in uremia?

Perna AF, Luciano MG, Pulzella P, Satta E, Capasso R, Lombardi C, Ingrosso D, De Santo NG. Perna AF, et al. Among authors: de santo ng. J Ren Nutr. 2008 Jan;18(1):12-7. doi: 10.1053/j.jrn.2007.10.005. J Ren Nutr. 2008. PMID: 18089438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

354 results

Search Page